We break down the current state of frontotemporal dementia, from bvFTD to PPA, and why 'promising' therapies are still far ...

Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and ...

SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- Shanghai Zhimeng Biopharma Inc. ( "Zhimeng") announced that its self-developed new-generation potassium channel opener CB03-154 for the treatment of amyotrophic ...

When Lewis Moody revealed this week that he had been diagnosed with motor neurone disease (MND), the reaction was instant, and visceral. Within hours, tributes flooded in for the former England ...

We present a case of a Caucasian woman aged 67 years referred with a 4-day history of sore throat, dysphagia, fever and nasal blockage. Examination revealed a swollen neck and pharyngeal ...

Introduction This study investigated factors contributing to failure of domiciliary non-invasive ventilation (NIV) in patients with Motor Neurone Disease (MND), including a cohort of patients with ...

Amylyx Pharmaceuticals is ending development of its AMX0035 drug candidate in the rare and fatal neurodegenerative disease progressive supranuclear palsy, or PSP, following the failure of a mid-stage ...